A tissue factor-cascade-targeted nanoparticle forsite-directed inducing thrombosis

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Vascular Biology

Background:

• Tissue factor is crucial in thrombosis and overexpressed in pathological conditions.
• Targeting tissue factor offers a strategy for localized disease intervention.
• Nanoparticle-based drug delivery systems are advancing therapeutic approaches.

Purpose of the Study:

• To develop and evaluate a tissue factor cascade-targeted strategy for inducing local thrombosis.
• To assess the efficacy of combining engineered nanoparticles with photochemistry for targeted therapy.
• To investigate the potential application of this strategy in treating hypervascular diseases.

Main Methods:

• Conjugation of protein EGFP-EGF1 to nanoparticles (ENP-HMME) to enhance uptake by tissue factor-overexpressing cells.
• In vitro studies to confirm nanoparticle uptake by brain capillary endothelial cells.
• In vivo 3D imaging and specklegram analysis to confirm thrombosis induction.
• In vivo multispectral fluorescent imaging to assess nanoparticle accumulation.

Main Results:

• Engineered nanoparticles showed significant uptake by tissue factor-overexpressing cells in vitro.
• The tissue factor cascade-targeted strategy successfully induced thrombosis at the desired location in vivo.
• Photochemistry combined with ENP-HMME led to higher accumulation in the infarction hemisphere compared to NP-HMME.
• The strategy demonstrated potential for localized thrombosis induction.

Conclusions:

• The developed tissue factor cascade-targeted strategy effectively induces local thrombosis.
• Combining ENP-HMME with photochemistry enhances targeted accumulation in infarction areas.
• This approach holds promise for the treatment of various hypervascular diseases.